decanoic acid acetic acid-anhydride

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: decanoic acid acetic acid-anhydride
• 英文别名: Decansaeure-essigsaeure-anhydrid；Decanoyl ethanoate；acetyl decanoate
• 化学式: C₁₂H₂₂O₃
• 分子量: 214.305
• InChiKey: WJRFQBPIMGRYOY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  15
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  乙烯酮 、 正癸酸 在 乙醚 作用下， 生成 decanoic acid acetic acid-anhydride
  参考文献：
  名称：

  Dunbar; Garven, Journal of the American Chemical Society, 1955, vol. 77, p. 4761

  摘要：

  DOI：

文献信息

• MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
  申请人：OBEREGGER Werner

  公开号：US20080038348A1

  公开（公告）日：2008-02-14

  The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.

  本发明涉及药物组合物、配方和药物，包括一种丁螺环酮盐，特别是包括有效量的丁螺环酮氢溴酸盐的缓释片剂，以及使用丁螺环酮盐来制备治疗疾病的药物。
• BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
  申请人：WILLIAMS Parry Robert

  公开号：US20080075774A1

  公开（公告）日：2008-03-27

  Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.

  本文描述了Bupropion hydrobromide配方及其用于治疗疾病的使用。
• Modified release formulations of a bupropion salt
  申请人：Oberegger Werner

  公开号：US20070027213A1

  公开（公告）日：2007-02-01

  The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.

  本发明涉及制药组合物、配方和药物，包括丁丙腈酮盐，特别是包含有效量的丁丙腈酮羟溴盐的改良释放片剂，以及使用丁丙腈酮盐制备治疗疾病的药物。
• BUPROPION HYDROBROMIDE POLYMORPHS
  申请人：TURCHETTA Stefano

  公开号：US20100068270A1

  公开（公告）日：2010-03-18

  Polymorphous and amorphous forms of bupropion hydrobromide are described.

  描述了盐酸布洛芬的多形和无定形形式。
• Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
  申请人：McDaniel C. Steven

  公开号：US20100210745A1

  公开（公告）日：2010-08-19

  Disclosed herein are polymeric materials such as a coating, a plastic, a laminate, a composite, an elastomer, an adhesive, or a sealant; a surface treatment such as a textile finish or a wax; a filler for such a polymeric material or a surface treatment that includes an enzyme such as an esterase (e.g., a lipolytic enzyme, a sulfuric ester hydrolase, an organophosphorus compound degradation enzyme), an enzyme (e.g., a lysozyme, a lytic transglycosylase) that degrades a cell wall and/or a cell membrane component, a biocidal or biostatic peotide, and/or a peptidase. Also disclosed herein are methods of altering a material's property such as service life, flexability, or rigidity, by incorporation of an enzyme into a material capable of being chemically crosslinked by the activity of a lipolytic enzyme, a hydrolase, and/or a urease.

  本文公开了一些聚合材料，如涂层、塑料、层压板、复合材料、弹性体、粘合剂或密封剂；一种表面处理，如纺织品涂层或蜡；一种填料，用于这样的聚合材料或表面处理，其中包括一种酶，如酯酶（例如，脂肪水解酶，硫酸酯水解酶，有机磷化合物降解酶），降解细胞壁和/或细胞膜成分的酶（例如，溶菌酶，裂解转糖基酶），生物杀菌或生物静态肽，以及/或肽酶。本文还公开了通过将酶纳入可通过脂肪水解酶、水解酶和/或脲酶的活性交联材料中来改变材料性能，如使用寿命、柔韧性或刚度的方法。